Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Prepaid Assets: 2017-2024

Historic Prepaid Assets for Arcus Biosciences (RCUS) over the last 8 years, with Dec 2024 value amounting to $18.0 million.

  • Arcus Biosciences' Prepaid Assets fell 31.82% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year decrease of 31.82%. This contributed to the annual value of $18.0 million for FY2024, which is 47.06% down from last year.
  • As of FY2024, Arcus Biosciences' Prepaid Assets stood at $18.0 million, which was down 47.06% from $34.0 million recorded in FY2023.
  • Arcus Biosciences' 5-year Prepaid Assets high stood at $34.0 million for FY2023, and its period low was $5.5 million during FY2020.
  • Over the past 3 years, Arcus Biosciences' median Prepaid Assets value was $19.0 million (recorded in 2022), while the average stood at $23.7 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first spiked by 229.01% in 2021, then crashed by 47.06% in 2024.
  • Arcus Biosciences' Prepaid Assets (Yearly) stood at $5.5 million in 2020, then soared by 229.01% to $18.0 million in 2021, then rose by 5.56% to $19.0 million in 2022, then spiked by 78.95% to $34.0 million in 2023, then tumbled by 47.06% to $18.0 million in 2024.